logo

Corporate Strategy of GlaxoSmithKline Plc

15 Pages4383 Words209 Views
   

Added on  2021-02-19

Corporate Strategy of GlaxoSmithKline Plc

   Added on 2021-02-19

ShareRelated Documents
CORPORATESTRATEGY
Corporate Strategy of GlaxoSmithKline Plc_1
Corporate Strategy of GlaxoSmithKline Plc_2
Table of ContentsINTRODUCTION...........................................................................................................................1EXTERNAL ANALYSIS................................................................................................................1PESTLE Analysis...................................................................................................................1Porter's Five Forces Analysis.................................................................................................3INTERNAL ANALYSIS.................................................................................................................5TOWS Analysis......................................................................................................................5Value Chain Analysis.............................................................................................................6VRIO Analysis.......................................................................................................................6EVALUATION................................................................................................................................8SAFe Criteria..........................................................................................................................8CONCLUSION..............................................................................................................................10REFERENCES..............................................................................................................................11
Corporate Strategy of GlaxoSmithKline Plc_3
INTRODUCTIONCorporate Strategy means a series of actions or steps which a company undertake in orderto achieve their organisational objectives in a sustainable and competitive manner. It providescompanies, effective and essential direction which helps as well as assists an organisation to gainthe necessary edge within the wider business environment that also helps in ensuring long termsustainability within the market (Adner, 2017). The assignment below is based uponGlaxoSmithKline Plc, which is situated in the UK and is one of the biggest pharmaceuticalcompanies within the nation. Currently, the firm is planning to effectively create a ConsumerHealthcare Joint Venture with Pfizer, which is its US-based rival company, operating underpharmaceutical industry within the UK. Thus, the report emphasises on a detailed externalanalysis to identify opportunities and threats prevailing in the environment for the firm alongwith a brief internal analysis to determine the competencies available with the company.Additionally, the assignment also covers evaluation of this strategy of joint venture using SAFCriteria.EXTERNAL ANALYSISPESTLE AnalysisFor a large organisation like GSK, it becomes necessary to analyse the externalenvironment of the business which is essential in terms of determining all the opportunities alongwith the threats which prevails in the environment and could possibly affect the strategy of thefirm. For this purpose, PESTLE Analysis is being used which is a framework used to analyseexternal pointers that are discussed in detail below:Political Factors:These factors are associated with the political functionality of a company and its likelyeffects which could be experienced by an industry. In context with the pharmaceutical industryof the UK, the political scenario is being quite uncertain due to the approaching events of Brexitand has surely an impact on this sector too. There is an uncertainty in the political front of thecountry due to the British exit from the EU. Thus, there are several ineffective regulations thatare likely to be imposed in relation to the free flowing of the goods in EU nations. This couldpossibly be a threat for the industry as production and distribution of pharmaceutical productsdepend heavily on the regulations imposed by government (The UK Pharmaceutical Industry1
Corporate Strategy of GlaxoSmithKline Plc_4

End of preview

Want to access all the pages? Upload your documents or become a member.

Related Documents
Corporate Strategy Force - Pestle Analysis
|15
|4206
|31

PESTLE Analysis of the Retail Sector
|17
|5350
|194

Applied Corporate Strategy
|13
|4143
|53

Applied Corporate Strategy
|16
|5062
|97

Strategic Analysis of Joint GSK and PFIZER Report 2022
|24
|5408
|34

Applied Corporate Strategy: Vodafone Plc
|13
|3779
|79